Activation of GPIIb/IIIa is known to require agonistinduced inside-out signaling through G q , G i , and G z . Although activated by several platelet agonists, including thrombin and thromboxane A 2 , the contribution of the G 12/13 signaling pathway to GPIIb/IIIa activation has not been investigated. In this study, we used selective stimulation of G protein pathways to investigate the contribution of G 12/13 activation to platelet fibrinogen receptor activation. YFLLRNP is a PAR-1-specific partial agonist that, at low concentrations (60 M), selectively activates the G 12/13 signaling cascade resulting in platelet shape change without stimulating the G q or G i signaling pathways. YFLLRNP-mediated shape change was completely inhibited by the p160 ROCK inhibitor, Y-27632. At this low concentration, YFLLRNP-mediated G 12/13 signaling caused platelet aggregation and enhanced PAC-1 binding when combined with selective G i or G z signaling, via selective stimulation of the P2Y 12 receptor or ␣ 2A -adrenergic receptor, respectively. Similar data were obtained when using low dose U46619 (10 nM), a thromboxane A 2